Host: Mario R. Nacinovich, Jr., MSc 


Guest: Sara Tolaney MD, MPH 



  Triple-negative breast cancer comprises up to 20 percent of all breast cancer diagnoses, and unfortunately, survival for these patients has been more limited than in other subtypes of disease. That’s why improving outcomes for patients with triple-negative breast cancer has been the focus of recent studies—much like the one investigating eribulin and pembrolizumab that Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute, presented at the 2020 ASCO Annual Meeting.  

Investigating Combination Therapies for Triple-Negative Breast Cancer

Advances in Women’s Health addresses advances, breakthroughs, and treatments for conditions related to women’s health, as well as preventive measures physicians can advise their patients to pursue. Topics will include breast health as it relates to cancer, ethnicity, fertility, and pregnancy; osteoporosis; female athletes’ health and emotional issues; mental health; pregnancy and all facets related to it; aging; nutrition and health; eating disorders; alternative medicine; and sex education.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Host: Jennifer Caudle, DO 


  Guest: Rosanne Kho, MD 



  
    To learn how Myfembree® (relugolix, estradiol, norethindrone acetate) could help address uterine fibroid-associated heavy menstrual bleeding or moderate to severe endometriosis pain in premenopausal women; listen to Dr. Jennifer Caudle and Dr. Rosanne Kho, Chair of the OB/GYN Department at the University of Arizona College of Medicine in Phoenix. Please scroll for Important Safety Information. Please see full Prescribing Information including BOXED WARNING here.

A Treatment Option for Heavy Menstrual Bleeding Due to Uterine Fibroids or Moderate to Severe Pain Due to Endometriosis in Premenopausal Women

Host: Blake Zwerling, MD 



  
    The Society of Family Planning and the Society of Maternal Fetal Medicine have released updated guidelines for medication abortion. Tune in as Dr. Blake Zwerling, Assistant Clinical Professor of Complex Family Planning, reviews these updates and shares how they can be used in clinical practice.

Reviewing Updated Guidelines for Medication Abortion

Guest: Christena Raines, NP 



  
    Perinatal mood disorders are among the most common complications during pregnancy and immediately following delivery. So front line providers need to be able to initiate treatment. Perinatal Psychiatric Nurse Practitioner and Adjunct Professor of Psychiatry at UNC Chapel Hill, Christena Raines, discusses her session at the 26th Annual Nurse Practitioners in Women’s Healthcare Conference and the importance of recognizing and treating perinatal mood disorders in our female patients.

Educating Nurse Practitioners on Perinatal Mental Health

Guest: Dawn Kimberly Hopkins, PhD, WHNP-BC 



  
    Understanding the manifestations of polycystic ovary syndrome (PCOS) can help to identify this condition in women better. And though it’s a common condition, some providers are unaware of how to diagnose it. Dig into the pathophysiology of PCOS with Dr. Dawn Kimberly Hopkins, Research Associate at the Henry Jackson Foundation in Bethesda, Maryland.

Improving Outcomes for Patients with PCOS

Guest: Genevieve Hofmann, NP 



  
    Menopause can impact everyday life, and many women go untreated for their menopausal symptoms. To learn more about some of the complex issues surrounding menopause management, join Dr. Genevieve Hofmann, Women’s Health Nurse Practitioner, Certified Menopause Clinician, and Assistant Professor of OB/GYN Health at the University of Colorado School of Medicine, who will be discussing these strategies at the 2023 Annual NPWH Women’s Healthcare Conference. 

Investigating Combination Therapies for Triple-Negative Breast Cancer

Download our free app to listen on your phone